{
    "16E.F": {
        "short_name": "EPISURF MEDICAL AB B",
        "long_name": "Episurf Medical AB (publ)",
        "summary": "Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in the Nordic countries, Benelux, Germany, the United Kingdom, and internationally. The company offers Episealer Condyle Solo for the treatment of localized cartilage and underlying bone defects on the femoral condyles of the knee joint; Episealer Trochlea Solo to treat localized cartilage and underlying bone defects in the area behind the patella; and Episealer Femoral Twin for the treatment of elongated localized cartilage and underlying bone defects on the femoral condyles and in the trochlea area of the knee joint. It also provides Episealer Talus for osteochondral lesions of the talar dome of the ankle joint; and Epiguide, a patient-specific drill guide for the treatment of painful joints. In addition, the company offers \u00c2\u00b5iFidelity system, a web-based IT platform for damage assessment, surgical pre-planning, and patient customization of implants and related surgical instruments; and Epioscopy, a damage assessment tool. The company was formerly known as Diamorph Medtech AB and changed its name to Episurf Medical AB (publ) in 2010. Episurf Medical AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Stockholm",
        "zipcode": "114 49",
        "website": "http://episurf.com",
        "market_cap": "Small Cap"
    },
    "2FV.F": {
        "short_name": "SCANDIDOS AB (PUBL)",
        "long_name": "ScandiDos AB (publ)",
        "summary": "ScandiDos AB (publ) provides measurement systems and software designed for the QA and validation requirements of the new treatments implemented in clinics worldwide. The company offers Delta4 Family solution for pre treatment and at treatment dose verification covering various treatment technologies, such as VMAT, IMRT, SBRT, 4D-RT, and TomoTherapy; Delta4 Discover, a transmission detector that provides confidence and patient safety based on real time measurements; and Delta4 Phantom+, a system that offers accurate and verification of IMRT, VMAT, and TomoTherapy plans. It also provides HexaMotion, a motion management solution; Delta4DVH Anatomy, a software that verifies and analyzes the dose delivered in the patient anatomy; Delta4 Machine QA, a software to perform QA with respect to rotation, start-up behavior, and dynamic beam modulation; and Delta4 Trolley, an ergonomic solution. The company is headquartered in Uppsala, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Uppsala",
        "zipcode": "751 83",
        "website": "http://scandidos.com",
        "market_cap": "Small Cap"
    },
    "2HJ.F": {
        "short_name": "BRIGHTER AB (PUBL)",
        "long_name": "Brighter AB (publ)",
        "summary": "Brighter AB (publ), a health-tech company, develops data-driven solutions for the treatment of chronic condition in Sweden. It is developing Actiste, a mobile-connected device to remotely monitor and treat insulin-dependent diabetes; and The Benefit Loop, a cloud-based platform that gathers, processes, analyzes, and organizes real-life data. The company offers its products to consumers and patients, mobile network operators, healthcare providers, governments/authorities, insurance companies, consumers, companies/employers, clinical research organizations, pharmaceutical companies, research and development organizations, authorities, and academic bodies. Brighter AB (publ) was founded in 2007 and is based in Kista, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Kista",
        "zipcode": "164 32",
        "website": "http://brighter.se",
        "market_cap": "Small Cap"
    },
    "2OK.F": {
        "short_name": "SPECTRACURE AB",
        "long_name": "SpectraCure AB (publ)",
        "summary": "SpectraCure AB (publ) focuses on cancer treatment utilizing laser light sources and photo reactive drugs. It develops IDOSE software with interstitial photodynamic therapy system, which is in Phase II clinical trial for the treatment of solid tumors. The company was founded in 2003 and is based in Lund, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Lund",
        "zipcode": "222 29",
        "website": "http://www.spectracure.com",
        "market_cap": "Small Cap"
    },
    "49Z.F": {
        "short_name": "CELLINK AB AK B  O.N.",
        "long_name": "Cellink AB (publ)",
        "summary": "Cellink AB (publ), a bio convergence company, designs and develops bioprinting, liquid handling, single-cell analysis, and live-cell imaging technologies in North America, Europe, Asia, and internationally. The company's bioprinting solutions include BIO MDX, bioprinting systems for biomedical manufacturing; BIO X, 3D bioprinter for cell biologists, tissue engineers and biomedical researchers; BIO X6, a 6 printhead 3D bioprinter; INKREDIBLE and INKREDIBLE+, which are 3D bioprinting solutions; Holograph X, provides ultra-high-resolution 3D bioprinting at the micrometer level using holographic stereolithography; and Lumen X, a solution that offers applications in microfluidics, cell-laden hydrogels, macroporous structures. It also offers C.BIRD, a microbioreactor for cell line development, as well as SOLARIS BIOREACTORS, a platforms for research and development, and product development applications; UP.SIGHT, a cell line development solution; Single-Cell Printer, an automated laboratory instrument; C.SIGHT, a single-cell dispensing technology for cell line development and single-cell genomics; B.SIGHT, a solution that enables prokaryotic cell isolation in the sub-micron range; and F.SIGHT, a solution that dispenses unlabeled and fluorescent cells. In addition, the company provides I-DOT, a solution for liquid-handling tasks; C.WASH, a plate washer; LIVECYTE, a kinetic cytometer; CELLCYTE X, a live cell imaging system; and CASY, a cell status monitoring solution, as well as open qPCR system and NGS reagents. Further, it offers consumables, and hand sanitizers and sanitizing wipes. The company serves universities, research organizations, pharmaceutical companies, and cosmetic and skin care companies, as well as packaging and automotive industries. It has strategic partnership with Made In Space for advancing bioprinting technology in space. The company also offers products online. Cellink AB (publ) was founded in 2016 and is headquartered in Gothenburg, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Gothenburg",
        "zipcode": "413 46",
        "website": "http://www.cellink.com",
        "market_cap": "Mid Cap"
    },
    "4HG.F": {
        "short_name": "QLIFE HOLDING AB",
        "long_name": "Qlife Holding AB (publ)",
        "summary": "Qlife Holding AB (publ), a high-tech medical device company, manufactures and sells in-vitro diagnostic analyzers and reagents. It offers Egoo Home System, an integrated platform consisting of a small home device and disposable capsules each of that test for a specific biomarker, as well as a digital infrastructure that shares data with patient journal or hospital platform. The company has a research agreement with Nordsj\u00c3\u00a6llands Hospital to continue the validation of the Egoo Sars-CoV-2 virus test. The company was founded in 2019 and is based in Helsingborg, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Helsingborg",
        "zipcode": "252 21",
        "website": "http://qlifeholding.com/en",
        "market_cap": "Small Cap"
    },
    "4Z7.F": {
        "short_name": "IRRAS AB",
        "long_name": "IRRAS AB (publ)",
        "summary": "IRRAS AB (publ), a medical device company, focuses on the delivery of medical solutions to enhance the lives of critically ill patients worldwide. It designs, develops, and commercializes neurocritical care products that transform patient outcomes and addresses complications associated with current treatment methodologies. The company offers IRRAflow, an irrigating intracranial drainage system that combines controlled drainage, automated irrigation, and integrated monitoring of intracranial pressure (ICP) for the treatment of patients suffering from hemorrhagic strokes and chronic subdural hematoma. It also provides Hummingbird ICP monitoring system comprising Hummingbird ICP Control Module (HICP200) and the related catheters, which include Hummingbird Quad ICP monitoring with drainage (H610), and Hummingbird Solo ICP monitoring (H110); and Hummingbird neuromonitoring products to manage patients suffering from conditions that cause an elevated intracranial pressure, including traumatic brain injury, subarachnoid hemorrhage, and strokes. The company markets and sells its products to hospitals through its direct sales force and a network of distribution partners. IRRAS AB (publ) was incorporated in 2011 and is headquartered in Stockholm, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Stockholm",
        "zipcode": "111 20",
        "website": "http://www.irras.com",
        "market_cap": "Small Cap"
    },
    "5J3.F": {
        "short_name": "SCIBASE HOLDING AB",
        "long_name": "SciBase Holding AB (publ)",
        "summary": "SciBase Holding AB (publ), a medical technology company, develops and sells instruments for the detection of skin cancer and other skin conditions.in Europe and internationally. The company offers Nevisense, a point-of-care detection device for non-visual detection of malignant melanoma. It serves public hospitals and private dermatology clinics. The company has a collaboration agreement with Swiss Institute of Allergy and Asthma Research. The company was founded in 1998 and is headquartered in Stockholm, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Stockholm",
        "zipcode": "172 63",
        "website": "http://www.scibase.com",
        "market_cap": "Small Cap"
    },
    "5J6.F": {
        "short_name": "OSSDSIGN AB",
        "long_name": "OssDsign AB (publ)",
        "summary": "OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally. Its products include OSSDSIGN cranial, an implant solution for cranioplasty patients, as well as related accessories; OSSDSIGN facial to treat patients with complex facial skeletal defects; and OSSDSIGN Cranioplug for bone flap fixation and burr hole coverage, as well as nanosynthetic bone graft substitute for treating skeletal defect. The company was incorporated in 2011 and is headquartered in Uppsala, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Uppsala",
        "zipcode": "754 50",
        "website": "http://www.ossdsign.com",
        "market_cap": "Small Cap"
    },
    "5JE.F": {
        "short_name": "BACTIGUARD HLDG B",
        "long_name": "Bactiguard Holding AB (publ)",
        "summary": "Bactiguard Holding AB (publ), a medical device company, engages in the research and development, production, marketing, and sale of infection prevention solutions. Its infection prevention solutions prevent healthcare associated infections caused by medical devices. The company's products portfolio reduces the risk of infections in the urinary tract, the respiratory tract, and the bloodstream. Its product portfolio consists of Bactiguard infection protection (BIP) Foley Catheter, an indwelling urinary catheter that reduces microbial adhesion; BIP Central Venous Catheter, which reduces the risk of biofilm formation and infection; BIP Endotracheal Tube that reduces the risk of infection; BIP Endotracheal Tube Evac, which is used to reduce microbial adhesion; and BIP Foley TempSensor, an indwelling urinary catheter that combines surveillance and infection prevention. The company's products also include Hydrocyn aqua advanced wound care, a wound wash, debridement, and irrigation solution for chronic and acute wounds; surgical sutures comprise of non-absorbable, natural absorbable, synthetic absorbable, and specialty sutures; VigiMesh, a sterile, non-absorbable, and knitted polypropylene monofilament mesh material for tissue reinforcement for use in hernia repair; and Hydrocyn aqua advanced disinfectant, a non-alcoholic disinfectant for skin and surfaces to kill bacteria, virus, and fungi. The company serves in the United States, Sweden, Malaysia, China, Thailand, Bangladesh, New Zealand, and internationally. Bactiguard Holding AB (publ) was founded in 2005 and is headquartered in Tullinge, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Tullinge",
        "zipcode": "146 21",
        "website": "http://www.bactiguard.com",
        "market_cap": "Small Cap"
    },
    "61LA.F": {
        "short_name": "SECTRA AB B(P.S.)SK 0,125",
        "long_name": "Sectra AB (publ)",
        "summary": "Sectra AB (publ) provides IT systems for managing medical images and patient information related to diagnostic imaging. The company's Imaging IT Solutions segment develops and sells medical IT systems and services for managing, archiving, and presenting various types of medical images and patient information, as well as for operational follow-up and radiation dose monitoring; maintenance services in the form of support and system monitoring; and consulting services related to integration, system design, data migration, and business development. Its Secure Communications segment develops and sells products and services for secure voice and data communications, and protection of society's sensitive IT infrastructure; customized encryption systems and products; and critical infrastructure, which offers security and threat analyses and system monitoring services for control systems in society's critical operations. The company's Business Innovation segment develops and sells IT systems for planning and monitoring orthopedic surgery; and products for medical education and research projects. It serves public and private healthcare providers comprising hospitals, and hospital and private clinic chains; and government agencies and defense departments. Sectra AB (publ) sells its products through its sales organizations and distribution partners in Africa, Europe, the Middle East, North America, Oceania, Southeast Asia, and Japan. The company was founded in 1978 and is headquartered in Link\u00c3\u00b6ping, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Link\u00c3\u00b6ping",
        "zipcode": "583 30",
        "website": "http://www.sectra.com",
        "market_cap": "Mid Cap"
    },
    "6YC.F": {
        "short_name": "SENZIME AB AK",
        "long_name": "Senzime AB (publ)",
        "summary": "Senzime AB (publ) develps and markets patient monitoring systems to monitor patients under anesthesia in Europe and the United States. The company offers TetraGraph, a TOF-monitor that stimulates, measures, analyzes, and displays muscle function in surgical patients receiving neuromuscular blocking agents; CliniSenz Analyzer, which detects early signs of complications; and Onzurf Probe for sampling from the surface of an organ. Senzime AB (publ) was founded in 1999 and is based in Uppsala, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Uppsala",
        "zipcode": "756 51",
        "website": "http://www.senzime.com",
        "market_cap": "Small Cap"
    },
    "782.F": {
        "short_name": "SCANDINAV. REAL HEART AB",
        "long_name": "Scandinavian Real Heart AB (Publ)",
        "summary": "Scandinavian Real Heart AB (Publ) designs and develops an artificial heart. The company engages in developing total artificial heart that provides solutions to patients diagnosed with advanced congestive heart failure. It also develops Realheart VAD, Realheart PulsePump, and Realheart Sternal prosthetic products. The company was founded in 2007 and is based in V\u00c3\u00a4ster\u00c3\u00a5s, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "V\u00c3\u00a4ster\u00c3\u00a5s",
        "zipcode": "722 13",
        "website": "http://realheart.se",
        "market_cap": "Small Cap"
    },
    "7AC.F": {
        "short_name": "ACARIX AB",
        "long_name": "Acarix AB (publ)",
        "summary": "Acarix AB (publ), a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases. The company offers CADScor System for the diagnosis of coronary artery disease. It operates in Germany, Sweden, Denmark, and internationally. Acarix AB (publ) was founded in 2009 and is headquartered in Malm\u00c3\u00b6, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Malm\u00c3\u00b6",
        "zipcode": "211 19",
        "website": "http://www.acarix.com",
        "market_cap": "Small Cap"
    },
    "ACARIX.ST": {
        "short_name": "Acarix AB",
        "long_name": "Acarix AB (publ)",
        "summary": "Acarix AB (publ), a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases. The company offers CADScor System for the diagnosis of coronary artery disease. It operates in Germany, Sweden, Denmark, and internationally. Acarix AB (publ) was founded in 2009 and is headquartered in Malm\u00c3\u00b6, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Malm\u00c3\u00b6",
        "zipcode": "211 19",
        "website": "http://www.acarix.com",
        "market_cap": "Small Cap"
    },
    "ADDV-A.ST": {
        "short_name": "ADDvise Group AB A",
        "long_name": "ADDvise Group AB (publ)",
        "summary": "ADDvise Group AB (publ) develops and supplies equipment and services to healthcare and research facilities in private and public sectors in Sweden, rest of Europe, North America, and Asia. The company's Lab business unit offers laboratory furnishings, safety ventilation products, climate rooms, clean rooms, and laboratory apparatus. Its Healthcare business unit develops, manufactures, and markets vacuum mattresses, pillows and splints, and vacuum products, as well as equipment for pilots, such as flight suits and Anti-G suits; healthcare equipment, such as bags and carrying systems, as well as equipment and consumable materials, such as intra-osseous and biopsy needles; equipment for patient positioning, primarily within urology and gynecology areas; and surgical tables for medical care. The company was formerly known as ADDvise Lab Solutions AB (publ) and changed its name to ADDvise Group AB (publ) in September 2015. ADDvise Group AB (publ) was founded in 1989 and is headquartered in Stockholm, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Stockholm",
        "zipcode": "114 46",
        "website": "http://www.addvisegroup.se",
        "market_cap": "Small Cap"
    },
    "ADDV-B.ST": {
        "short_name": "ADDvise Group AB B",
        "long_name": "ADDvise Group AB (publ)",
        "summary": "ADDvise Group AB (publ) develops and supplies equipment and services to healthcare and research facilities in private and public sectors in Sweden, rest of Europe, North America, and Asia. The company's Lab business unit offers laboratory furnishings, safety ventilation products, climate rooms, clean rooms, and laboratory apparatus. Its Healthcare business unit develops, manufactures, and markets vacuum mattresses, pillows and splints, and vacuum products, as well as equipment for pilots, such as flight suits and Anti-G suits; healthcare equipment, such as bags and carrying systems, as well as equipment and consumable materials, such as intra-osseous and biopsy needles; equipment for patient positioning, primarily within urology and gynecology areas; and surgical tables for medical care. The company was formerly known as ADDvise Lab Solutions AB (publ) and changed its name to ADDvise Group AB (publ) in September 2015. ADDvise Group AB (publ) was founded in 1989 and is headquartered in Stockholm, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Stockholm",
        "zipcode": "114 46",
        "website": "http://www.addvisegroup.se",
        "market_cap": "Small Cap"
    },
    "ARCOMA.ST": {
        "short_name": "Arcoma AB",
        "long_name": "Arcoma AB",
        "summary": "Arcoma AB develops, produces, and provides radiology solutions worldwide. It offers digital x-ray and radiography systems for radiographic applications, as well as for use in general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. The company sells its products through OEM partners. Arcoma AB was founded in 1990 and is based in V\u00c3\u00a4xj\u00c3\u00b6, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "V\u00c3\u00a4xj\u00c3\u00b6",
        "zipcode": "352 46",
        "website": "http://www.arcoma.se",
        "market_cap": "Small Cap"
    },
    "BACTI-B.ST": {
        "short_name": "Bactiguard Holding AB ser. B",
        "long_name": "Bactiguard Holding AB (publ)",
        "summary": "Bactiguard Holding AB (publ), a medical device company, engages in the research and development, production, marketing, and sale of infection prevention solutions. Its infection prevention solutions prevent healthcare associated infections caused by medical devices. The company's products portfolio reduces the risk of infections in the urinary tract, the respiratory tract, and the bloodstream. Its product portfolio consists of Bactiguard infection protection (BIP) Foley Catheter, an indwelling urinary catheter that reduces microbial adhesion; BIP Central Venous Catheter, which reduces the risk of biofilm formation and infection; BIP Endotracheal Tube that reduces the risk of infection; BIP Endotracheal Tube Evac, which is used to reduce microbial adhesion; and BIP Foley TempSensor, an indwelling urinary catheter that combines surveillance and infection prevention. The company's products also include Hydrocyn aqua advanced wound care, a wound wash, debridement, and irrigation solution for chronic and acute wounds; surgical sutures comprise of non-absorbable, natural absorbable, synthetic absorbable, and specialty sutures; VigiMesh, a sterile, non-absorbable, and knitted polypropylene monofilament mesh material for tissue reinforcement for use in hernia repair; and Hydrocyn aqua advanced disinfectant, a non-alcoholic disinfectant for skin and surfaces to kill bacteria, virus, and fungi. The company serves in the United States, Sweden, Malaysia, China, Thailand, Bangladesh, New Zealand, and internationally. Bactiguard Holding AB (publ) was founded in 2005 and is headquartered in Tullinge, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Tullinge",
        "zipcode": "146 21",
        "website": "http://www.bactiguard.com",
        "market_cap": "Small Cap"
    },
    "BRIG.ST": {
        "short_name": "Brighter AB",
        "long_name": "Brighter AB (publ)",
        "summary": "Brighter AB (publ), a health-tech company, develops data-driven solutions for the treatment of chronic condition in Sweden. It is developing Actiste, a mobile-connected device to remotely monitor and treat insulin-dependent diabetes; and The Benefit Loop, a cloud-based platform that gathers, processes, analyzes, and organizes real-life data. The company offers its products to consumers and patients, mobile network operators, healthcare providers, governments/authorities, insurance companies, consumers, companies/employers, clinical research organizations, pharmaceutical companies, research and development organizations, authorities, and academic bodies. Brighter AB (publ) was founded in 2007 and is based in Kista, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Kista",
        "zipcode": "164 32",
        "website": "http://brighter.se",
        "market_cap": "Small Cap"
    },
    "C26.F": {
        "short_name": "CELLAVISION AB  SK -,15",
        "long_name": "CellaVision AB (publ)",
        "summary": "CellaVision AB (publ) develops and sells digital solutions for blood and body fluids analysis in health care services sector in Sweden, Europe, the Middle East, Africa, the Americas, and the Asia Pacific. It offers reagents, analyzers, supplementary software, and peripheral equipment for digital microscopy in the field of hematology. The company also provides CellaVision DM1200 and CellaVision DM9600, which automatically capture digital images of cells from blood smears and body fluid preparations; and CellaVision DC-1, an analyzer. In addition, it offers CellaVision Peripheral Blood Application that enables laboratories to automate, standardize, and simplify morphological examination of peripheral blood smears; CellaVision Advanced RBC Application, which enables to perform comprehensive examination of red blood cell morphology; CellaVision Body Fluid Application that enables laboratories to automate, standardize, and simplify morphological examination of body fluid preparations; and CellaVision Remote Review Software, which removes restrictive geographical constraints from the smear review process. Further, the company provides CellaVision Server Software that creates a single streamlined workflow within one or multiple testing sites; CellaVision Dashboard, a tool designed to give an at-a-glance view of CellaVision analyzer and reviewer metrics; CellaVision Proficiency Software, a cloud-based software designed to help laboratory managers assess, monitor, and promote staff competency in the area of cell morphology; CellaVision CellAtlas, which combines a series of mini lectures with an extensive cell image library; and CellaVision VET that offers digital solutions for medical microscopy in the field of hematology. It sells its products to hospital and commercial laboratories. CellaVision AB (publ) was incorporated in 1994 and is headquartered in Lund, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Lund",
        "zipcode": "223 62",
        "website": "http://www.cellavision.com",
        "market_cap": "Small Cap"
    },
    "CEVI.ST": {
        "short_name": "CellaVision AB",
        "long_name": "CellaVision AB (publ)",
        "summary": "CellaVision AB (publ) develops and sells digital solutions for blood and body fluids analysis in health care services sector in Sweden, Europe, the Middle East, Africa, the Americas, and the Asia Pacific. It offers reagents, analyzers, supplementary software, and peripheral equipment for digital microscopy in the field of hematology. The company also provides CellaVision DM1200 and CellaVision DM9600, which automatically capture digital images of cells from blood smears and body fluid preparations; and CellaVision DC-1, an analyzer. In addition, it offers CellaVision Peripheral Blood Application that enables laboratories to automate, standardize, and simplify morphological examination of peripheral blood smears; CellaVision Advanced RBC Application, which enables to perform comprehensive examination of red blood cell morphology; CellaVision Body Fluid Application that enables laboratories to automate, standardize, and simplify morphological examination of body fluid preparations; and CellaVision Remote Review Software, which removes restrictive geographical constraints from the smear review process. Further, the company provides CellaVision Server Software that creates a single streamlined workflow within one or multiple testing sites; CellaVision Dashboard, a tool designed to give an at-a-glance view of CellaVision analyzer and reviewer metrics; CellaVision Proficiency Software, a cloud-based software designed to help laboratory managers assess, monitor, and promote staff competency in the area of cell morphology; CellaVision CellAtlas, which combines a series of mini lectures with an extensive cell image library; and CellaVision VET that offers digital solutions for medical microscopy in the field of hematology. It sells its products to hospital and commercial laboratories. CellaVision AB (publ) was incorporated in 1994 and is headquartered in Lund, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Lund",
        "zipcode": "223 62",
        "website": "http://www.cellavision.com",
        "market_cap": "Small Cap"
    },
    "CLLKF": {
        "short_name": "CELLINK AB",
        "long_name": "Cellink AB (publ)",
        "summary": "Cellink AB (publ), a bio convergence company, designs and develops bioprinting, liquid handling, single-cell analysis, and live-cell imaging technologies in North America, Europe, Asia, and internationally. The company's bioprinting solutions include BIO MDX, bioprinting systems for biomedical manufacturing; BIO X, 3D bioprinter for cell biologists, tissue engineers and biomedical researchers; BIO X6, a 6 printhead 3D bioprinter; INKREDIBLE and INKREDIBLE+, which are 3D bioprinting solutions; Holograph X, provides ultra-high-resolution 3D bioprinting at the micrometer level using holographic stereolithography; and Lumen X, a solution that offers applications in microfluidics, cell-laden hydrogels, macroporous structures. It also offers C.BIRD, a microbioreactor for cell line development, as well as SOLARIS BIOREACTORS, a platforms for research and development, and product development applications; UP.SIGHT, a cell line development solution; Single-Cell Printer, an automated laboratory instrument; C.SIGHT, a single-cell dispensing technology for cell line development and single-cell genomics; B.SIGHT, a solution that enables prokaryotic cell isolation in the sub-micron range; and F.SIGHT, a solution that dispenses unlabeled and fluorescent cells. In addition, the company provides I-DOT, a solution for liquid-handling tasks; C.WASH, a plate washer; LIVECYTE, a kinetic cytometer; CELLCYTE X, a live cell imaging system; and CASY, a cell status monitoring solution, as well as open qPCR system and NGS reagents. Further, it offers consumables, and hand sanitizers and sanitizing wipes. The company serves universities, research organizations, pharmaceutical companies, and cosmetic and skin care companies, as well as packaging and automotive industries. It has strategic partnership with Made In Space for advancing bioprinting technology in space. The company also offers products online. Cellink AB (publ) was founded in 2016 and is headquartered in Gothenburg, Sweden.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Sweden",
        "state": null,
        "city": "Gothenburg",
        "zipcode": "413 46",
        "website": "http://www.cellink.com",
        "market_cap": "Mid Cap"
    },
    "CLNK-B.ST": {
        "short_name": "CELLINK AB ser. B",
        "long_name": "Cellink AB (publ)",
        "summary": "Cellink AB (publ), a bio convergence company, designs and develops bioprinting, liquid handling, single-cell analysis, and live-cell imaging technologies in North America, Europe, Asia, and internationally. The company's bioprinting solutions include BIO MDX, bioprinting systems for biomedical manufacturing; BIO X, 3D bioprinter for cell biologists, tissue engineers and biomedical researchers; BIO X6, a 6 printhead 3D bioprinter; INKREDIBLE and INKREDIBLE+, which are 3D bioprinting solutions; Holograph X, provides ultra-high-resolution 3D bioprinting at the micrometer level using holographic stereolithography; and Lumen X, a solution that offers applications in microfluidics, cell-laden hydrogels, macroporous structures. It also offers C.BIRD, a microbioreactor for cell line development, as well as SOLARIS BIOREACTORS, a platforms for research and development, and product development applications; UP.SIGHT, a cell line development solution; Single-Cell Printer, an automated laboratory instrument; C.SIGHT, a single-cell dispensing technology for cell line development and single-cell genomics; B.SIGHT, a solution that enables prokaryotic cell isolation in the sub-micron range; and F.SIGHT, a solution that dispenses unlabeled and fluorescent cells. In addition, the company provides I-DOT, a solution for liquid-handling tasks; C.WASH, a plate washer; LIVECYTE, a kinetic cytometer; CELLCYTE X, a live cell imaging system; and CASY, a cell status monitoring solution, as well as open qPCR system and NGS reagents. Further, it offers consumables, and hand sanitizers and sanitizing wipes. The company serves universities, research organizations, pharmaceutical companies, and cosmetic and skin care companies, as well as packaging and automotive industries. It has strategic partnership with Made In Space for advancing bioprinting technology in space. The company also offers products online. Cellink AB (publ) was founded in 2016 and is headquartered in Gothenburg, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Gothenburg",
        "zipcode": "413 46",
        "website": "http://www.cellink.com",
        "market_cap": "Mid Cap"
    },
    "CLS-B.ST": {
        "short_name": "Clinical Laserthermia Systems A",
        "long_name": "Clinical Laserthermia Systems AB (publ)",
        "summary": "Clinical Laserthermia Systems AB (publ) develops and markets therapies, systems, and single-use instruments for thermal treatment of solid cancer tumors in Sweden. The company offers TRANBERG, a cancer immunotherapy system that includes a laser unit with unique monitoring capabilities and tailored single-use products primarily developed for imILT treatment; and applicator kit. It also is developing products for the treatment of breast, pancreatic, skin, and prostate cancers, as well as other solid cancer tumors. Clinical Laserthermia Systems AB (publ) has a collaboration agreement with Image Guided Therapy SA to develop and commercialize a software product for MR-generated temperature monitoring; collaborative license and co-development agreement with MRI Interventions, Inc. to provide navigation and laser ablation platforms for use in spine and neurosurgery; and clinical trial collaboration with Toronto General Hospital regarding MRI-guided laser ablation treatment of prostate cancer. The company is headquartered in Lund, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Lund",
        "zipcode": "223 81",
        "website": "http://www.clinicallaser.se",
        "market_cap": "Small Cap"
    },
    "CRAD-B.ST": {
        "short_name": "C-RAD AB ser. B",
        "long_name": "C-Rad AB (publ)",
        "summary": "C-Rad AB (publ), together with its subsidiaries, develops, manufactures, and sells systems with applications in radiation therapy for the treatment of cancer worldwide. The company operates through two segments, Positioning and Imaging. Its products include Sentinel 4D CT, a laser-based optical surface scanning system; Catalyst, a 4D surface image guided radiation therapy (SIGRT) solution; Catalyst HD, an SIGRT solution on stereotactic radiation therapy for online patient tracking before and during treatment delivery; Catalyst+, an SIGRT solution for high precision patient positioning, intra-fraction motion management, and respiratory gating; and Catalyst+ HD, a solution for high precision patient positioning, intra-fraction motion management, and respiratory gating for conventional and stereotactic treatment delivery. The company's products also comprise Catalyst Tomo, an enhanced positioning solution for tomotherapy; Catalyst PT, a real-time tracking solution for particle therapy; Cyrpa laser positioning products; cAccessory, which automates the registration and validation of treatment accessories; and cPatient that automates patient identity validation without the need for contact between patients and devices. In addition, it offers installation, application training, and aftersales services. C-Rad AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Uppsala",
        "zipcode": "753 09",
        "website": "http://www.c-rad.se",
        "market_cap": "Small Cap"
    },
    "DIGN.ST": {
        "short_name": "Dignitana AB",
        "long_name": "Dignitana AB (publ.)",
        "summary": "Dignitana AB (publ.), a medical technology company, develops, produces, and markets medical cooling devices primarily in the United States. It offers DigniCap, a scalp cooling system used to reduce hair loss from certain chemotherapy treatments, as well as in the treatment of breast cancer. Dignitana AB (publ.) was incorporated in 2007 is headquartered in Lund, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Lund",
        "zipcode": "226 60",
        "website": "http://dignitana.com",
        "market_cap": "Small Cap"
    },
    "DIZTF": {
        "short_name": "DIGNITANA AB",
        "long_name": "Dignitana AB (publ.)",
        "summary": "Dignitana AB (publ.), a medical technology company, develops, produces, and markets medical cooling devices primarily in the United States. It offers DigniCap, a scalp cooling system used to reduce hair loss from certain chemotherapy treatments, as well as in the treatment of breast cancer. Dignitana AB (publ.) was incorporated in 2007 is headquartered in Lund, Sweden.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Sweden",
        "state": null,
        "city": "Lund",
        "zipcode": "226 60",
        "website": "http://dignitana.com",
        "market_cap": "Small Cap"
    },
    "EPIS-B.ST": {
        "short_name": "Episurf Medical AB B",
        "long_name": "Episurf Medical AB (publ)",
        "summary": "Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in the Nordic countries, Benelux, Germany, the United Kingdom, and internationally. The company offers Episealer Condyle Solo for the treatment of localized cartilage and underlying bone defects on the femoral condyles of the knee joint; Episealer Trochlea Solo to treat localized cartilage and underlying bone defects in the area behind the patella; and Episealer Femoral Twin for the treatment of elongated localized cartilage and underlying bone defects on the femoral condyles and in the trochlea area of the knee joint. It also provides Episealer Talus for osteochondral lesions of the talar dome of the ankle joint; and Epiguide, a patient-specific drill guide for the treatment of painful joints. In addition, the company offers \u00c2\u00b5iFidelity system, a web-based IT platform for damage assessment, surgical pre-planning, and patient customization of implants and related surgical instruments; and Epioscopy, a damage assessment tool. The company was formerly known as Diamorph Medtech AB and changed its name to Episurf Medical AB (publ) in 2010. Episurf Medical AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Stockholm",
        "zipcode": "114 49",
        "website": "http://episurf.com",
        "market_cap": "Small Cap"
    },
    "EPSFF": {
        "short_name": "EPISURF MEDICAL AB",
        "long_name": "Episurf Medical AB (publ)",
        "summary": "Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in the Nordic countries, Benelux, Germany, the United Kingdom, and internationally. The company offers Episealer Condyle Solo for the treatment of localized cartilage and underlying bone defects on the femoral condyles of the knee joint; Episealer Trochlea Solo to treat localized cartilage and underlying bone defects in the area behind the patella; and Episealer Femoral Twin for the treatment of elongated localized cartilage and underlying bone defects on the femoral condyles and in the trochlea area of the knee joint. It also provides Episealer Talus for osteochondral lesions of the talar dome of the ankle joint; and Epiguide, a patient-specific drill guide for the treatment of painful joints. In addition, the company offers \u00c2\u00b5iFidelity system, a web-based IT platform for damage assessment, surgical pre-planning, and patient customization of implants and related surgical instruments; and Epioscopy, a damage assessment tool. The company was formerly known as Diamorph Medtech AB and changed its name to Episurf Medical AB (publ) in 2010. Episurf Medical AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Sweden",
        "state": null,
        "city": "Stockholm",
        "zipcode": "114 49",
        "website": "http://episurf.com",
        "market_cap": "Small Cap"
    },
    "GPXMED.ST": {
        "short_name": "GPX Medical AB",
        "long_name": "GPX Medical AB (publ)",
        "summary": "GPX Medical AB operates as a medical technology company. It offers neonatal intensive care with NEOLA, a medical device that offer continuous lung monitoring and real-time alerts of life-threatening complications using technology that measures lung volume changes and oxygen gas concentration. NEOLA provide intensive care and healthier lives for preterm born infants. The company was founded in 2016 and headquartered in Lund, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Lund",
        "zipcode": "227 30",
        "website": "http://gasporox.se/medical-diagnostics/",
        "market_cap": "Small Cap"
    },
    "HEMC.ST": {
        "short_name": "Hemcheck Sweden AB",
        "long_name": "Hemcheck Sweden AB (publ)",
        "summary": "Hemcheck Sweden AB (publ) operates as a medical technology company in Sweden. The company develops and commercializes Helge, which detects hemolysis in blood samples at the point of care. It serves emergency departments in the European Union and the United States. The company was founded in 2010 and is based in Karlstad, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Karlstad",
        "zipcode": "651 88",
        "website": "http://www.hemcheck.com",
        "market_cap": "Small Cap"
    },
    "ICO.ST": {
        "short_name": "Iconovo AB",
        "long_name": "Iconovo AB (publ)",
        "summary": "Iconovo AB (publ) develops and licenses inhalation devices in Sweden. It develops ICOres, a reservoir-based dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a unit dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler, as well as provides customized inhalation solutions. It serves generic companies. The company has an agreement with Immune System Regulation AB for the development of an inhaled covid-19 vaccine in Iconovo's inhaler ICOone. Iconovo AB (publ) was founded in 2013 and is headquartered in Lund, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Lund",
        "zipcode": "223 81",
        "website": "http://www.iconovo.se",
        "market_cap": "Small Cap"
    },
    "IRRAS.ST": {
        "short_name": "IRRAS AB",
        "long_name": "IRRAS AB (publ)",
        "summary": "IRRAS AB (publ), a medical device company, focuses on the delivery of medical solutions to enhance the lives of critically ill patients worldwide. It designs, develops, and commercializes neurocritical care products that transform patient outcomes and addresses complications associated with current treatment methodologies. The company offers IRRAflow, an irrigating intracranial drainage system that combines controlled drainage, automated irrigation, and integrated monitoring of intracranial pressure (ICP) for the treatment of patients suffering from hemorrhagic strokes and chronic subdural hematoma. It also provides Hummingbird ICP monitoring system comprising Hummingbird ICP Control Module (HICP200) and the related catheters, which include Hummingbird Quad ICP monitoring with drainage (H610), and Hummingbird Solo ICP monitoring (H110); and Hummingbird neuromonitoring products to manage patients suffering from conditions that cause an elevated intracranial pressure, including traumatic brain injury, subarachnoid hemorrhage, and strokes. The company markets and sells its products to hospitals through its direct sales force and a network of distribution partners. IRRAS AB (publ) was incorporated in 2011 and is headquartered in Stockholm, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Stockholm",
        "zipcode": "111 20",
        "website": "http://www.irras.com",
        "market_cap": "Small Cap"
    },
    "LS6.F": {
        "short_name": "CLINICAL LASERTHERM.SYS B",
        "long_name": "Clinical Laserthermia Systems AB (publ)",
        "summary": "Clinical Laserthermia Systems AB (publ) develops and markets therapies, systems, and single-use instruments for thermal treatment of solid cancer tumors in Sweden. The company offers TRANBERG, a cancer immunotherapy system that includes a laser unit with unique monitoring capabilities and tailored single-use products primarily developed for imILT treatment; and applicator kit. It also is developing products for the treatment of breast, pancreatic, skin, and prostate cancers, as well as other solid cancer tumors. Clinical Laserthermia Systems AB (publ) has a collaboration agreement with Image Guided Therapy SA to develop and commercialize a software product for MR-generated temperature monitoring; collaborative license and co-development agreement with MRI Interventions, Inc. to provide navigation and laser ablation platforms for use in spine and neurosurgery; and clinical trial collaboration with Toronto General Hospital regarding MRI-guided laser ablation treatment of prostate cancer. The company is headquartered in Lund, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Lund",
        "zipcode": "223 81",
        "website": "http://www.clinicallaser.se",
        "market_cap": "Small Cap"
    },
    "LUR.F": {
        "short_name": "LUXBRIGHT AB",
        "long_name": "Luxbright AB (publ)",
        "summary": "Luxbright AB, a technology company, develops and commercializes X-ray tubes, generators, and other X-ray systems to system suppliers. The company was founded in 2012 and is based in Gothenburg, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Gothenburg",
        "zipcode": "41346",
        "website": "http://luxbright.com",
        "market_cap": "Small Cap"
    },
    "LXB.ST": {
        "short_name": "Luxbright AB",
        "long_name": "Luxbright AB (publ)",
        "summary": "Luxbright AB, a technology company, develops and commercializes X-ray tubes, generators, and other X-ray systems to system suppliers. The company was founded in 2012 and is based in Gothenburg, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Gothenburg",
        "zipcode": "41346",
        "website": "http://luxbright.com",
        "market_cap": "Small Cap"
    },
    "MN2.F": {
        "short_name": "MENTICE AB  SK -,20",
        "long_name": "Mentice AB (publ)",
        "summary": "Mentice AB (publ) provides endovascular simulation solutions to the hospitals and training centers, and medical device manufacturers worldwide. The company operates through three segments: Medical Device Industry, Teaching Entities, and Healthcare systems. The company provides software modules in the areas of acute ischemic stroke intervention, aortic valve implantation, atrial septal defect and patent foramen ovale occlusion, below-the-knee intervention, cardiac rhythm management, carotid intervention, coronary angiography, coronary PRO, endovascular aortic repair, Iliac/SFA intervention, left atrial appendage occlusion, neurovascular intervention, peripheral angiography, prostatic artery embolization, renal denervation, renal intervention, thoracic endovascular aortic repair, transarterial chemoembolization, transseptal puncture, uterine artery embolization, and vascular trauma management. It offers flight simulations to physicians and clinical teams. The company's products are used to educate, train, and improve the practitioner's skills in different types of interventions and new clinical instruments. The company was founded in 1999 and is headquartered in Gothenburg, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Gothenburg",
        "zipcode": "411 03",
        "website": "http://www.mentice.com",
        "market_cap": "Small Cap"
    },
    "MNTC.ST": {
        "short_name": "Mentice AB",
        "long_name": "Mentice AB (publ)",
        "summary": "Mentice AB (publ) provides endovascular simulation solutions to the hospitals and training centers, and medical device manufacturers worldwide. The company operates through three segments: Medical Device Industry, Teaching Entities, and Healthcare systems. The company provides software modules in the areas of acute ischemic stroke intervention, aortic valve implantation, atrial septal defect and patent foramen ovale occlusion, below-the-knee intervention, cardiac rhythm management, carotid intervention, coronary angiography, coronary PRO, endovascular aortic repair, Iliac/SFA intervention, left atrial appendage occlusion, neurovascular intervention, peripheral angiography, prostatic artery embolization, renal denervation, renal intervention, thoracic endovascular aortic repair, transarterial chemoembolization, transseptal puncture, uterine artery embolization, and vascular trauma management. It offers flight simulations to physicians and clinical teams. The company's products are used to educate, train, and improve the practitioner's skills in different types of interventions and new clinical instruments. The company was founded in 1999 and is headquartered in Gothenburg, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Gothenburg",
        "zipcode": "411 03",
        "website": "http://www.mentice.com",
        "market_cap": "Small Cap"
    },
    "OSSD.ST": {
        "short_name": "OssDsign AB",
        "long_name": "OssDsign AB (publ)",
        "summary": "OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally. Its products include OSSDSIGN cranial, an implant solution for cranioplasty patients, as well as related accessories; OSSDSIGN facial to treat patients with complex facial skeletal defects; and OSSDSIGN Cranioplug for bone flap fixation and burr hole coverage, as well as nanosynthetic bone graft substitute for treating skeletal defect. The company was incorporated in 2011 and is headquartered in Uppsala, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Uppsala",
        "zipcode": "754 50",
        "website": "http://www.ossdsign.com",
        "market_cap": "Small Cap"
    },
    "P75.F": {
        "short_name": "PHARMACOLOG I UPPSALA AB",
        "long_name": "Pharmacolog i Uppsala AB (publ)",
        "summary": "Pharmacolog i Uppsala AB (publ) develops systems and solutions for use of intravenous drugs in Sweden. The company offers DrugLog, a solution for reducing errors in the drug administration process; WasteLog, an integrated system to monitor and safeguard discarded narcotics from surgical procedures; and PerpLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of end result. The company was founded in 2007 and is based in Uppsala, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Uppsala",
        "zipcode": "752 75",
        "website": "http://www.pharmacolog.com",
        "market_cap": "Small Cap"
    },
    "PAX.ST": {
        "short_name": "Paxman AB",
        "long_name": "Paxman AB (publ)",
        "summary": "Paxman AB (publ), together with its subsidiaries, develops and sells PAXMAN scalp cooling system for minimizing hair loss in connection with chemotherapy treatment in Europe, North and South America, Central America, Asia, and Oceania. It serves various cancer centers and hospitals. Paxman AB (Publ) has a research collaboration agreement with National University Hospital, Singapore for the development of portable cooling and compression device. The company was founded in 1996 and is headquartered in Karlshamn, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Karlshamn",
        "zipcode": "374 35",
        "website": "http://www.paxman.se",
        "market_cap": "Small Cap"
    },
    "PHLOG-B.ST": {
        "short_name": "Pharmacolog i Uppsala AB ser. B",
        "long_name": "Pharmacolog i Uppsala AB (publ)",
        "summary": "Pharmacolog i Uppsala AB (publ) develops systems and solutions for use of intravenous drugs in Sweden. The company offers DrugLog, a solution for reducing errors in the drug administration process; WasteLog, an integrated system to monitor and safeguard discarded narcotics from surgical procedures; and PerpLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of end result. The company was founded in 2007 and is based in Uppsala, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Uppsala",
        "zipcode": "752 75",
        "website": "http://www.pharmacolog.com",
        "market_cap": "Small Cap"
    },
    "PXMBF": {
        "short_name": "PAXMAN AB",
        "long_name": "Paxman AB (publ)",
        "summary": "Paxman AB (publ), together with its subsidiaries, develops and sells PAXMAN scalp cooling system for minimizing hair loss in connection with chemotherapy treatment in Europe, North and South America, Central America, Asia, and Oceania. It serves various cancer centers and hospitals. Paxman AB (Publ) has a research collaboration agreement with National University Hospital, Singapore for the development of portable cooling and compression device. The company was founded in 1996 and is headquartered in Karlshamn, Sweden.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Sweden",
        "state": null,
        "city": "Karlshamn",
        "zipcode": "374 35",
        "website": "http://www.paxman.se",
        "market_cap": "Small Cap"
    },
    "QLIFE.ST": {
        "short_name": "QLife Holding AB",
        "long_name": "Qlife Holding AB (publ)",
        "summary": "Qlife Holding AB (publ), a high-tech medical device company, manufactures and sells in-vitro diagnostic analyzers and reagents. It offers Egoo Home System, an integrated platform consisting of a small home device and disposable capsules each of that test for a specific biomarker, as well as a digital infrastructure that shares data with patient journal or hospital platform. The company has a research agreement with Nordsj\u00c3\u00a6llands Hospital to continue the validation of the Egoo Sars-CoV-2 virus test. The company was founded in 2019 and is based in Helsingborg, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Helsingborg",
        "zipcode": "252 21",
        "website": "http://qlifeholding.com/en",
        "market_cap": "Small Cap"
    },
    "S21.F": {
        "short_name": "S2MEDICAL AB B",
        "long_name": "S2Medical AB (publ)",
        "summary": "S2Medical AB (publ) develops, produces, and sells wound healing products for burns and chronic wounds. It offers INSTAQRETT, a sterile single use mechanical debridement tool; EPIPROTECT SafeStop for blood stilling; Instagraft, a single-use medical device for the treatment of chronic and complicated wounds; EPIPROTECT tissue substitutes; and washable, waterproof, and self-adhesive bandages under the INSTABIND brand name. The company also distributes Silverlon dressings that deliver silver ions into the wound. In addition, it operates wound healing center under the S2Clinic name. The company was founded in 2013 and is headquartered in Link\u00c3\u00b6ping, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Link\u00c3\u00b6ping",
        "zipcode": "582 73",
        "website": "http://www.s2m.se",
        "market_cap": "Small Cap"
    },
    "S2M.ST": {
        "short_name": "S2Medical AB ser. B",
        "long_name": "S2Medical AB (publ)",
        "summary": "S2Medical AB (publ) develops, produces, and sells wound healing products for burns and chronic wounds. It offers INSTAQRETT, a sterile single use mechanical debridement tool; EPIPROTECT SafeStop for blood stilling; Instagraft, a single-use medical device for the treatment of chronic and complicated wounds; EPIPROTECT tissue substitutes; and washable, waterproof, and self-adhesive bandages under the INSTABIND brand name. The company also distributes Silverlon dressings that deliver silver ions into the wound. In addition, it operates wound healing center under the S2Clinic name. The company was founded in 2013 and is headquartered in Link\u00c3\u00b6ping, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Link\u00c3\u00b6ping",
        "zipcode": "582 73",
        "website": "http://www.s2m.se",
        "market_cap": "Small Cap"
    },
    "SCIB.ST": {
        "short_name": "Scibase Holding AB",
        "long_name": "SciBase Holding AB (publ)",
        "summary": "SciBase Holding AB (publ), a medical technology company, develops and sells instruments for the detection of skin cancer and other skin conditions.in Europe and internationally. The company offers Nevisense, a point-of-care detection device for non-visual detection of malignant melanoma. It serves public hospitals and private dermatology clinics. The company has a collaboration agreement with Swiss Institute of Allergy and Asthma Research. The company was founded in 1998 and is headquartered in Stockholm, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Stockholm",
        "zipcode": "172 63",
        "website": "http://www.scibase.com",
        "market_cap": "Small Cap"
    },
    "SDOS.ST": {
        "short_name": "ScandiDos AB",
        "long_name": "ScandiDos AB (publ)",
        "summary": "ScandiDos AB (publ) provides measurement systems and software designed for the QA and validation requirements of the new treatments implemented in clinics worldwide. The company offers Delta4 Family solution for pre treatment and at treatment dose verification covering various treatment technologies, such as VMAT, IMRT, SBRT, 4D-RT, and TomoTherapy; Delta4 Discover, a transmission detector that provides confidence and patient safety based on real time measurements; and Delta4 Phantom+, a system that offers accurate and verification of IMRT, VMAT, and TomoTherapy plans. It also provides HexaMotion, a motion management solution; Delta4DVH Anatomy, a software that verifies and analyzes the dose delivered in the patient anatomy; Delta4 Machine QA, a software to perform QA with respect to rotation, start-up behavior, and dynamic beam modulation; and Delta4 Trolley, an ergonomic solution. The company is headquartered in Uppsala, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Uppsala",
        "zipcode": "751 83",
        "website": "http://scandidos.com",
        "market_cap": "Small Cap"
    },
    "SECT-B.ST": {
        "short_name": "SECTRA AB ser B",
        "long_name": "Sectra AB (publ)",
        "summary": "Sectra AB (publ) provides IT systems for managing medical images and patient information related to diagnostic imaging. The company's Imaging IT Solutions segment develops and sells medical IT systems and services for managing, archiving, and presenting various types of medical images and patient information, as well as for operational follow-up and radiation dose monitoring; maintenance services in the form of support and system monitoring; and consulting services related to integration, system design, data migration, and business development. Its Secure Communications segment develops and sells products and services for secure voice and data communications, and protection of society's sensitive IT infrastructure; customized encryption systems and products; and critical infrastructure, which offers security and threat analyses and system monitoring services for control systems in society's critical operations. The company's Business Innovation segment develops and sells IT systems for planning and monitoring orthopedic surgery; and products for medical education and research projects. It serves public and private healthcare providers comprising hospitals, and hospital and private clinic chains; and government agencies and defense departments. Sectra AB (publ) sells its products through its sales organizations and distribution partners in Africa, Europe, the Middle East, North America, Oceania, Southeast Asia, and Japan. The company was founded in 1978 and is headquartered in Link\u00c3\u00b6ping, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Link\u00c3\u00b6ping",
        "zipcode": "583 30",
        "website": "http://www.sectra.com",
        "market_cap": "Mid Cap"
    },
    "SEZI.ST": {
        "short_name": "Senzime AB",
        "long_name": "Senzime AB (publ)",
        "summary": "Senzime AB (publ) develps and markets patient monitoring systems to monitor patients under anesthesia in Europe and the United States. The company offers TetraGraph, a TOF-monitor that stimulates, measures, analyzes, and displays muscle function in surgical patients receiving neuromuscular blocking agents; CliniSenz Analyzer, which detects early signs of complications; and Onzurf Probe for sampling from the surface of an organ. Senzime AB (publ) was founded in 1999 and is based in Uppsala, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Uppsala",
        "zipcode": "756 51",
        "website": "http://www.senzime.com",
        "market_cap": "Small Cap"
    },
    "SPEC.ST": {
        "short_name": "SpectraCure AB",
        "long_name": "SpectraCure AB (publ)",
        "summary": "SpectraCure AB (publ) focuses on cancer treatment utilizing laser light sources and photo reactive drugs. It develops IDOSE software with interstitial photodynamic therapy system, which is in Phase II clinical trial for the treatment of solid tumors. The company was founded in 2003 and is based in Lund, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Lund",
        "zipcode": "222 29",
        "website": "http://www.spectracure.com",
        "market_cap": "Small Cap"
    },
    "STIL.ST": {
        "short_name": "Stille AB",
        "long_name": "Stille AB",
        "summary": "Stille AB manufactures and sells surgical instruments in Sweden and internationally. The company offers artery and ligature clamps; artery forceps; bone cutters and rongeurs; clamps; curettes, raspatories, elevators, etc.; forceps; micro instruments; needle holder, wire twistings, and holding forceps; osteotomes, chisels, etc.; reactors and skin hooks; scissors; and other products. It also provides operating tables for ERCP / abdominal fluoroscopy, neuro / spine, pain management, urology, and vascular surgeries. The company was founded in 1841 and is headquartered in Torsh\u00c3\u00a4lla, Sweden. Stille AB is a subsidiary of Linc AB.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Torsh\u00c3\u00a4lla",
        "zipcode": "644 30",
        "website": "http://www.stille.se",
        "market_cap": "Small Cap"
    },
    "VITR.ST": {
        "short_name": "Vitrolife AB",
        "long_name": "Vitrolife AB (publ)",
        "summary": "Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It offers oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also provides EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is headquartered in Gothenburg, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Gothenburg",
        "zipcode": "421 32",
        "website": "http://www.vitrolife.com",
        "market_cap": "Mid Cap"
    },
    "VTFN.F": {
        "short_name": "VITROLIFE AB  SK 0,2",
        "long_name": "Vitrolife AB (publ)",
        "summary": "Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It offers oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also provides EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is headquartered in Gothenburg, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Gothenburg",
        "zipcode": "421 32",
        "website": "http://www.vitrolife.com",
        "market_cap": "Mid Cap"
    },
    "XVIPF": {
        "short_name": "XVIVO PERFUSION AB",
        "long_name": "Xvivo Perfusion AB (publ)",
        "summary": "Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation. The company offers XVIVO Perfusion System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex-vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex, a buffered extracellular colloid-based electrolyte preservation solution; Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. Xvivo Perfusion AB (publ) was founded in 1998 and is headquartered in Gothenburg, Sweden.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Sweden",
        "state": null,
        "city": "Gothenburg",
        "zipcode": "400 14",
        "website": "http://www.xvivoperfusion.com",
        "market_cap": "Small Cap"
    },
    "XVIVO.ST": {
        "short_name": "Xvivo Perfusion AB",
        "long_name": "Xvivo Perfusion AB (publ)",
        "summary": "Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation. The company offers XVIVO Perfusion System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex-vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex, a buffered extracellular colloid-based electrolyte preservation solution; Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. Xvivo Perfusion AB (publ) was founded in 1998 and is headquartered in Gothenburg, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Gothenburg",
        "zipcode": "400 14",
        "website": "http://www.xvivoperfusion.com",
        "market_cap": "Small Cap"
    }
}